Effects of 4-week Sitagliptin or Exenatide Therapy on Endothelial Progenitor Cells in Type 2 Diabetic Patients. A Non-controlled Open-label Pilot Trial.

Trial Profile

Effects of 4-week Sitagliptin or Exenatide Therapy on Endothelial Progenitor Cells in Type 2 Diabetic Patients. A Non-controlled Open-label Pilot Trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Apr 2010

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 26 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Jan 2010 Actual patient number (40) added as reported by ClinicalTrials.gov.
    • 26 Jan 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top